Repeated 10b5-1 sales reported for VICR (VICR) by insider
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
Reported Form 144 sales of common stock by holders including 10b5-1 transactions. The excerpt lists multiple resale entries dated March through June 2026 showing individual sale dates, share counts and dollar amounts. Several rows identify PATRIZIO VINCIARELLI executing recurring 10b5-1 sales of common shares on numerous dates.
Positive
- None.
Negative
- None.
Key Figures
Single entry shares: 50,000 shares
Example proceeds: $9,809,142.46
Smaller block sale: 3,500 shares
+2 more
5 metrics
Single entry shares
50,000 shares
Multiple March 2026 sale rows showing 50,000-share transactions
Example proceeds
$9,809,142.46
Proceeds shown for a 50,000-share sale on <date>03/18/2026</date>
Smaller block sale
3,500 shares
Brigham and Women's Hospital sale on <date>05/14/2026</date> for $1,043,623.00
Top-line entry
20,000 shares
Header row showing 20,000 and $6,659,000.00 with date <date>06/03/2026</date>
Example proceeds
$9,666,511.00
Proceeds shown for a 50,000-share sale on <date>04/15/2026</date>
Key Terms
10b5-1, Form 144, Founders Shares
3 terms
10b5-1 regulatory
"10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Form 144 regulatory
"144: Securities Sold During The Past 3 Months"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.